Close Menu

This article has been updated with new information about Yourgene's stock offering.

NEW YORK – Yourgene Health said on Tuesday that it has agreed to acquire Coastal Genomics, a sample prep technology company based in Vancouver, British Columbia, for up to $13.5 million.

Yourgene plans to pay an initial $3 million in cash and $2.5 million in equity, and a contingent consideration of up to $8 million in cash and equity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.